Trading on the OTCBB, BioNeutral Group, Inc. is a specialty chemical technology based Life Science Company. BioNeutral Group, Inc. intends to commercialize a combinational chemistry-based technology. This technology can neutralize harmful environmental contaminants, toxins, and dangerous microorganisms. These include bacteria, viruses, mold, fungi, and spores. The Company has their headquarters at the New Jersey Institute of Technology/EDC in Newark, New Jersey.

The Company’s formulations include Ygieneâ„¢ and Ogieneâ„¢, both of which are eco-friendly and include natural and common ingredients. The Company has combined these widely used compounds in highly specialized ways to create products that significantly enhance disinfecting and cleaning results. BioNeutral’s proprietary platform technology has proven effective in surface, water, and airborne applications. Products include BioNeutralizers and ChemoNeutralizers.

BioNeutralizers, based on the company’s proprietary Ygieneâ„¢ platform, disinfect, decontaminate, and sterilize. BioNeutral’s corporate mission is to bring to market the broadest-based, fastest acting, most effective and safest anti-microbial known. The company believes this class of products has important applications for Healthcare Facilities, Consumers / Household use, Industrial Applications, as well as Military / Homeland Security.

ChemoNeutralizers, based on the Ogieneâ„¢ formula, irreversibly bind chemical contaminants and toxin molecules rendering them harmless. Applications for this product include industrial pollution, environmental contaminants, and protection against chemical weapons of mass destruction.

Today, BioNeutral Group, Inc. announced that independent lab test results conducted at Microbiotest Inc. of Sterling, Virginia demonstrated that Ygieneâ„¢ Consumer Grade Antimicrobial totally eradicated the H1N1 Swine Flu Virus in 20 seconds. This is a significantly milder and diluted variation of the Ygieneâ„¢ Hospital Grade Formulation. The independent testing shows that Ygieneâ„¢ Consumer Grade Antimicrobial equaled the performance of the company’s hospital grade formulation, and that the formulation is extremely effective against the Swine Flu.

BioNeutral Group Inc. CEO, Stephen J. Browand, stated, “BioNeutral’s Ygieneâ„¢ Consumer Grade Antimicrobial is an important addition to the Company’s growing list of formulations which will be presented to the EPA for regulatory approval.”